AbbVie Announces FDA and EMA Updates for Epcoritamab (EPKINLY/TEPKINLY) for the Treatment of…
AbbVie announced updates from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for epcoritamab, an investigational T-cell engaging bispecific antibody…
Read More...
Read More...